Wound Care Technologies: Sales Growth, Change, Global Forecast

MedMarket Diligence is hours away from publishing its 2015 report on the worldwide wound management market.

The report is entitled, “Worldwide Wound Management, Forecast to 2024: Established and Emerging Products, Technologies and Markets in the Americas, Europe, Asia/Pacific and Rest of World”. The report is described in detail at link.

The very diverse field that is wound management encompasses technologies from gauze to bioengineered skin and skin substitutes and many in between. Growth rates range from flat to over 15% annually through 2024.

Source: MedMarket Diligence, LLC; Report #S251.

The highest growth segments in medical technology sectors typically derive their high growth from modest absolute changes on very small volume and therefore rarely can sustain that growth over time. However, in wound management, the use of bioengineered skin and skin substitutes will result in the highest cumulative sales compared to all segments from 2015 to 2024 — excluding, that is, the high volume segments of traditional adhesives, gauzes, and non-adherent dressings.  Also noteworthy is the second highest cumulative sales over this period was for antimicrobial dressings, despite this segment having relatively modest growth on a percentage basis, but proceeding from significant sales in 2015 (already at over $1.5 billion).

Source: MedMarket Diligence, LLC; Report #S251.

During the forecast period, the most significant change evident in sales is the jump in the share of the market represented by bioengineered and other skin replacements, as noted above. But with compound annual growth rates (to 2024) in sales in the different wound segments ranging from near 1% to nearly 20% — for segments with 2015 sales at a low of $300 million and a high of $15 billion — there is considerable shifting of shares of the global wound market.

Source: MedMarket Diligence, LLC; Report #S251.

On a geographic basis, wound care technology migration, efforts to secure underserved patient caseload, and other forces result in growth rates that vary by country or region. The well-developed USA market therefore does not compare in uptake of both old and new technologies within growth markets like China and others in the Asia/Pacific region.

Source: MedMarket Diligence, LLC; Report #S251.

Medtech Startups, 2010-2015

From 2010 to present (Oct 2015), as included in the Medtech Startups Database, MedMarket Diligence identified 442 new (under one year old) medical technology startups whose businesses encompass, alone or in combination, medical devices, diagnostics, biomaterials, and the subset of both biotech and pharma that is in direct competition with medical devices, including tissue engineering and cell therapy. Of these, 74% were founded in the U.S., 5% were founded in Israel, and the rest were founded in 18 other countries.

Companies in the database have been categorized by clinical and/or technology area of focus, with multiple categories possible (e.g., minimally invasive and orthomusculoskeletal and surgery). Below is the composition of the companies identified from Jan. 2010 to Oct. 2015.

Screen Shot 2015-10-06 at 4.50.10 PM

Source: Medtech Startups Database

Below is a graphic on the companies by country. The U.S. (not shown) led with 327 companies.

Screen Shot 2015-10-06 at 4.17.30 PM

Source: Medtech Startups Database

In the U.S., the breakdown by state, other than California and its 466 companies (excluded only to show states with significantly lower numbers), is as follows:

Screen Shot 2015-10-06 at 5.13.08 PM

Source: Medtech Startups Database

 

Report: Worldwide Wound Management, Forecast to 2024

Pending Report Announcement

Worldwide Wound Management, Forecast to 2024:
Established and Emerging Products, Technologies and Markets
in the Americas, Europe, Asia/Pacific and Rest of World
· 350 pages · 200 Exhibits · 75 Company Profiles · Report #S251 · November/December 2015
(Click for full report description)

Price: $4,250 (print or PDF; add $200 for both).
Pre-publication $1,000 discount.
Site/Global License also available.

Order online or send us your order form.

This report will detail the complete range of products and technologies used in wound management and wound care, from dressings, bandages, hydrogels, tissue engineered products, physical treatments and others. The report will detail current clinical and technology developments in the worldwide market providing a current assessment of products in development and on the market; market size and forecast; competitor market shares; 75-100 competitor profiles; and an assessment of the market opportunity for current and hopeful competitors.

The report will provide full year (actual) 2014 market size and share data, with forecast market data to 2024, for the Americas (with detail for U.S., Rest of North America and Latin America), Europe (with detail for United Kingdom, Germany, France, Spain, Italy, and Rest of Europe), Asia/Pacific (with detail for Japan, Korea, and Rest of Asia/Pacific) and Rest of World.

This report will detail the current and projected market for wound management products, including dressings, closure devices, debridement, pharmacological products, tissue engineered products and others. Emphasis will be placed on advanced and leading edge developments (i.e., those approaching wound management from novel perspective) such as growth factors, stem cells, gene therapy and other approaches, while baseline data (current and forecast market size and current competitor market shares per country) will be provided for established segments — multiple dressings types (film, foam, alginate, antibacterial, non-adherent), hydrogels, hydrocolloids, pharmaceuticals, and physical treatments. The report will detail the clinical and technology developments underlying the clinical practice and market development in wound care market, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity. Separate size, growth and competitor data are presented for the U.S., rest of North America, Latin America, leading western European countries (specifically, United Kingdom, Germany, France, Italy, Spain), rest of Europe, Japan, Korea, rest of Asia/Pacific, and the Rest of World category. The report’s company profiles will assess leading and key emerging companies regarding current/projected products, technologies and positions in the advanced wound care market.

TABLE OF CONTENTS
EXECUTiVE SUMMARY
SECTION 1: INDUSTRY BACKGROUND
1.1. Industry Structure
1.2. A Complex Industry
1.3. Historical Perspective and Technology Breakthroughs
1.4. Wound Management Trends
1.4.1. Surgical Wounds
1.4.2. Traumatic Wounds
1.4.3. Burns
1.4.4. Chronic Wounds
1.5. Market Dynamics
SECTION 2: CLINICAL BACKGROUND AND CASELOAD
2.1. Background
2.2. Skin Anatomy: A Summary
2.3. Types of Wounds
2.3.1. Classification
2.3.1.1. Wagner Classification System
2.3.1.2. By Severity
2.3.1.3. By Morphology
2.3.1.4. By Etiology
2.3.1.5. Color Classification
2.3.2. Surgical Wounds
2.3.3. Traumatic Wounds
2.3.4. Burns
2.3.4.1. Debridement
2.3.4.2. Grafting
2.3.5. Pressure Ulcers
2.3.5.1. Ulcer Classification
2.3.5.2. Hospital-Acquired Ulcers
2.3.6. Venous Ulcers
2.3.7. Arterial Ulcers
2.3.8. Diabetic Ulcers
2.3.8.1. Prevalence
2.3.8.2. Stages of Diabetic Ulcers
2.3.8.3. Treatment
2.3.8.4. Amputations
2.3.8.5. Novel treatment for Diabetic Foot Ulcers
2.4. Wound Healing Physiology
2.4.1. Inflammatory Phase
2.4.2. Proliferative Phase
2.4.3. Angiogenesis
2.4.4. Maturation Phase
2.5. Factors Affecting Wound Healing
2.5.1. Extrinsic Factors
2.5.1.1. Mechanical Stress
2.5.1.2. Debris
2.5.1.3. Temperature
2.5.1.4. Desiccation and Maceration
2.5.1.5. Infection
2.5.1.6. Chemical Stress
2.5.1.7. Medication
2.5.1.8. Other Extrinsic Factors
2.5.2. Intrinsic Factors
2.5.2.1. Health Status
2.5.2.1.1. Acquired Immune Deficiency Syndrome
2.5.2.2. Age Factors
2.5.2.3. Body Build
2.5.2.4. Nutritional Status
2.6. Major Treatment Categories and Regimens
2.7. Incidence of Treatments, Growth Rates and Trends
SECTION 3: PRODUCTS, TECHNOLOGIES AND MARKETS
3.1. Background
3.2. Traditional Wound Care Products
3.2.1. Adhesive Dressings
3.2.1.1. Market and Competitive Activity
3.2.2. Gauze
3.2.2.1. Market and Competitive Activity
3.2.3. Non-Adherent Dressings
3.2.3.1. Market and Competitive Activity
3.3. Interactive Wound Healing Products
3.3.1. Film Dressings
3.3.1.1. Overview
3.3.1.2. Leading Products and Other Product Examples
3.3.1.3. Market and Competitive Activity
3.3.2. Foam Dressings
3.3.2.1. Overview
3.3.2.2. Leading Products and Other Product Examples
3.3.2.3. Market and Competitive Activity
3.3.3. Hydrogels
3.3.3.1. Overview
3.3.3.2. Leading Products and Other Product Examples
3.3.3.3. Market and Competitive Activity
3.4. Bioactive Wound Healing Products
3.4.1. Hydrocolloids
3.4.1.1. Overview
3.4.1.2. Leading Products and Other Product Examples
3.4.1.3. Market and Competitive Activity
3.4.2. Alginate Dressings
3.4.2.1. Overview
3.4.2.2. Market and Competitive Activity
3.4.2.3. Leading Products and Other Product Examples
3.4.3. Antimicrobial Dressings
3.4.3.1. Overview
3.4.3.2. Leading Products and Other Product Examples
3.4.3.3. Market and Competitive Activity
3.5. Biologics
3.5.1. Overview
3.5.2. Bioengineered Skin & Skin Substitutes
3.5.3. Market and Competitive Activity
3.6. Wound Care Devices
3.6.1. Negative Pressure Devices
3.6.1.1. Overview
3.6.1.2. Leading Products and Other Product Examples
3.6.1.3. Market and Competitive Activity
3.6.2. Ultrasound Devices
3.6.2.1. Overview
3.6.2.2. Leading Products and Other Product Examples
3.6.2.3. Market and Competitive Activity
3.6.3. Electrical Stimulation Devices
3.6.3.1. Overview
3.6.3.2. Pulsed Electromagnetic Therapy (PEMF)
3.7. Emerging Wound Therapy Technologies
3.7.1. Growth Factors: Introduction
3.7.2. Growth Factor Nomenclature
3.7.3. Developments in Growth Factors
3.7.4. Market and Competitive Activity
SECTION 4: COUNTRY MARKET FORECAST 2014-2024
4.1. Global Overview
4.2. Market Estimates
4.2.1. Global Market for Traditional Adhesive Dressings
4.2.2. Global Market for Traditional Gauze Dressings
4.2.3. Global Market for Non-Adherent Dressings
4.2.4. Global Market for Film Dressings
4.2.5. Global Market for Foam Dressings
4.2.6. Global Market for Hydrogel Dressings
4.2.7. Global Market for Hydrocolloid Dressings
4.2.8. Global Market for Alginate Dressings
4.2.9. Global Market for Antimicrobial Dressings
4.2.10. Global Market for Negative Pressure Wound Therapy
4.2.11. Global Market for Bioengineered Skin & Skin Substitutes
4.2.12. Global Market for Wound Care Growth Factors
4.3. Market Potential
4.4. Leading Companies in the Wound Management Market
4.5. Competitor Market Shares by Product
4.5.1. Market Shares by Country for Traditional Adhesive Dressings
4.5.1.1. United States
4.5.1.2. Rest of North America
4.5.1.3. Latin America
4.5.1.4. EU
4.5.1.4.1. United Kingdom
4.5.1.4.2. Germany
4.5.1.4.3. France
4.5.1.4.4. Italy
4.5.1.4.5. Spain
4.5.1.4.6. Rest of EU
4.5.1.5. Asia Pacific
4.5.1.5.1. Japan
4.5.1.5.2. Korea
4.5.1.5.3. Rest of Asia Pacific
4.5.1.6. Rest of World
4.5.2. Market Shares by Country for Traditional Gauze Dressings
4.5.2.1. United States
4.5.2.2. Rest of North America
4.5.2.3. Latin America
4.5.2.4. EU
4.5.2.4.1. United Kingdom
4.5.2.4.2. Germany
4.5.2.4.3. France
4.5.2.4.4. Italy
4.5.2.4.5. Spain
4.5.2.4.6. Rest of EU
4.5.2.5. Asia Pacific
4.5.2.5.1. Japan
4.5.2.5.2. Korea
4.5.2.5.3. Rest of Asia Pacific
4.5.2.6. Rest of World
4.5.3. Market Shares by Country for Non-Adherent Dressings
4.5.3.1. United States
4.5.3.2. Rest of North America
4.5.3.3. Latin America
4.5.3.4. EU
4.5.3.4.1. United Kingdom
4.5.3.4.2. Germany
4.5.3.4.3. France
4.5.3.4.4. Italy
4.5.3.4.5. Spain
4.5.3.4.6. Rest of EU
4.5.3.5. Asia Pacific
4.5.3.5.1. Japan
4.5.3.5.2. Korea
4.5.3.5.3. Rest of Asia Pacific
4.5.3.6. Rest of World
4.5.4. Market Shares by Country for Film Dressings
4.5.4.1. United States
4.5.4.2. Rest of North America
4.5.4.3. Latin America
4.5.4.4. EU
4.5.4.4.1. United Kingdom
4.5.4.4.2. Germany
4.5.4.4.3. France
4.5.4.4.4. Italy
4.5.4.4.5. Spain
4.5.4.4.6. Rest of EU
4.5.4.5. Asia Pacific
4.5.4.5.1. Japan
4.5.4.5.2. Korea
4.5.4.5.3. Rest of Asia Pacific
4.5.4.6. Rest of World
4.5.5. Market Shares by Country for Foam Dressings
4.5.5.1. United States
4.5.5.2. Rest of North America
4.5.5.3. Latin America
4.5.5.4. EU
4.5.5.4.1. United Kingdom
4.5.5.4.2. Germany
4.5.5.4.3. France
4.5.5.4.4. Italy
4.5.5.4.5. Spain
4.5.5.4.6. Rest of EU
4.5.5.5. Asia Pacific
4.5.5.5.1. Japan
4.5.5.5.2. Korea
4.5.5.5.3. Rest of Asia Pacific
4.5.5.6. Rest of World
4.5.6. Market Shares by Country for Hydrogel Dressings
4.5.6.1. United States
4.5.6.2. Rest of North America
4.5.6.3. Latin America
4.5.6.4. EU
4.5.6.4.1. United Kingdom
4.5.6.4.2. Germany
4.5.6.4.3. France
4.5.6.4.4. Italy
4.5.6.4.5. Spain
4.5.6.4.6. Rest of EU
4.5.6.5. Asia Pacific
4.5.6.5.1. Japan
4.5.6.5.2. Korea
4.5.6.5.3. Rest of Asia Pacific
4.5.6.6. Rest of World
4.5.7. Market Shares by Country for Hydrocolloid Dressings
4.5.7.1. United States
4.5.7.2. Rest of North America
4.5.7.3. Latin America
4.5.7.4. EU
4.5.7.4.1. United Kingdom
4.5.7.4.2. Germany
4.5.7.4.3. France
4.5.7.4.4. Italy
4.5.7.4.5. Spain
4.5.7.4.6. Rest of EU
4.5.7.5. Asia Pacific
4.5.7.5.1. Japan
4.5.7.5.2. Korea
4.5.7.5.3. Rest of Asia Pacific
4.5.7.6. Rest of World
4.5.8. Market Shares by Country for Alginate Dressings
4.5.8.1. United States
4.5.8.2. Rest of North America
4.5.8.3. Latin America
4.5.8.4. EU
4.5.8.4.1. United Kingdom
4.5.8.4.2. Germany
4.5.8.4.3. France
4.5.8.4.4. Italy
4.5.8.4.5. Spain
4.5.8.4.6. Rest of EU
4.5.8.5. Asia Pacific
4.5.8.5.1. Japan
4.5.8.5.2. Korea
4.5.8.5.3. Rest of Asia Pacific
4.5.8.6. Rest of World
4.5.9. Market Shares by Country for Antimicrobial Dressings
4.5.9.1. United States
4.5.9.2. Rest of North America
4.5.9.3. Latin America
4.5.9.4. EU
4.5.9.4.1. United Kingdom
4.5.9.4.2. Germany
4.5.9.4.3. France
4.5.9.4.4. Italy
4.5.9.4.5. Spain
4.5.9.4.6. Rest of EU
4.5.9.5. Asia Pacific
4.5.9.5.1. Japan
4.5.9.5.2. Korea
4.5.9.5.3. Rest of Asia Pacific
4.5.9.6. Rest of World
4.5.10. Market Shares by Country for Negative Pressure Wound Therapy
4.5.10.1. United States
4.5.10.2. Rest of North America
4.5.10.3. Latin America
4.5.10.4. EU
4.5.10.4.1. United Kingdom
4.5.10.4.2. Germany
4.5.10.4.3. France
4.5.10.4.4. Italy
4.5.10.4.5. Spain
4.5.10.4.6. Rest of EU
4.5.10.5. Asia Pacific
4.5.10.5.1. Japan
4.5.10.5.2. Korea
4.5.10.5.3. Rest of Asia Pacific
4.5.10.6. Rest of World
4.5.11. Market Shares by Country for Bioengineered Skin & Skin Substitutes
4.5.11.1. United States
4.5.11.2. Rest of North America
4.5.11.3. Latin America
4.5.11.4. EU
4.5.11.4.1. United Kingdom
4.5.11.4.2. Germany
4.5.11.4.3. France
4.5.11.4.4. Italy
4.5.11.4.5. Spain
4.5.11.4.6. Rest of EU
4.5.11.5. Asia Pacific
4.5.11.5.1. Japan
4.5.11.5.2. Korea
4.5.11.5.3. Rest of Asia Pacific
4.5.11.6. Rest of World
4.5.12. Market Shares by Country for Wound Care Growth Factors
4.5.12.1. United States
4.5.12.2. Rest of North America
4.5.12.3. Latin America
4.5.12.4. EU
4.5.12.4.1. United Kingdom
4.5.12.4.2. Germany
4.5.12.4.3. France
4.5.12.4.4. Italy
4.5.12.4.5. Spain
4.5.12.4.6. Rest of EU
4.5.12.5. Asia Pacific
4.5.12.5.1. Japan
4.5.12.5.2. Korea
4.5.12.5.3. Rest of Asia Pacific
4.5.12.6. Rest of World
4.6. Regional and Country Market Sizes
4.7. Americas
4.7.1. United States
4.7.1.1. USA Market for Traditional Adhesive Dressings
4.7.1.2. USA Market for Traditional Gauze Dressings
4.7.1.3. USA Market for Non-Adherent Dressings
4.7.1.4. USA Market for Film Dressings
4.7.1.5. USA Market for Foam Dressings
4.7.1.6. USA Market for Hydrogel Dressings
4.7.1.7. USA Market for Hydrocolloid Dressings
4.7.1.8. USA Market for Alginate Dressings
4.7.1.9. USA Market for Antimicrobial Dressings
4.7.1.10. USA Market for Negative Pressure Wound Therapy
4.7.1.11. USA Market for Bioengineered Skin & Skin Substitutes
4.7.1.12. USA Market for Wound Care Growth Factors
4.7.2. Rest of North America
4.7.2.1. Rest of North America Market for Traditional Adhesive Dressings
4.7.2.2. Rest of North America Market for Traditional Gauze Dressings
4.7.2.3. Rest of North America Market for Non-Adherent Dressings
4.7.2.4. Rest of North America Market for Film Dressings
4.7.2.5. Rest of North America Market for Foam Dressings
4.7.2.6. Rest of North America Market for Hydrogel Dressings
4.7.2.7. Rest of North America Market for Hydrocolloid Dressings
4.7.2.8. Rest of North America Market for Alginate Dressings
4.7.2.9. Rest of North America Market for Antimicrobial Dressings
4.7.2.10. Rest of North America Market for Negative Pressure Wound Therapy
4.7.2.11. Rest of North America Market for Bioengineered Skin and Skin Substitutes
4.7.2.12. Rest of North America Market for Wound Care Growth Factors
4.7.3. Latin America
4.7.3.1. Latin America Market for Traditional Adhesive Dressings
4.7.3.2. Latin America Market for Traditional Gauze Dressings
4.7.3.3. Latin America Market for Non-Adherent Dressings
4.7.3.4. Latin America Market for Film Dressings
4.7.3.5. Latin America Market for Foam Dressings
4.7.3.6. Latin America Market for Hydrogel Dressings
4.7.3.7. Latin America Market for Hydrocolloid Dressings
4.7.3.8. Latin America Market for Alginate Dressings
4.7.3.9. Latin America Market for Antimicrobial Dressings
4.7.3.10. Latin America Market for Negative Pressure Wound Therapy Devices
4.7.3.11. Latin America Market for Bioengineered Skin and Skin Substitutes
4.7.3.12. Latin America Market for Wound Care Growth Factors
4.8. European Union
4.8.1. United Kingdom
4.8.1.1. UK Market for Traditional Adhesive Dressings
4.8.1.2. UK Market for Traditional Gauze Dressings
4.8.1.3. UK Market for Non-Adherent Dressings
4.8.1.4. UK Market for Film Dressings
4.8.1.5. UK Market for Foam Dressings
4.8.1.6. UK Market for Hydrogel Dressings
4.8.1.7. UK Market for Hydrocolloid Dressings
4.8.1.8. UK Market for Alginate Dressings
4.8.1.9. UK Market for Antimicrobial Dressings
4.8.1.10. UK Market for Negative Pressure Wound Therapy Devices
4.8.1.11. UK Market Bioengineered Skin and Skin Substitutes
4.8.1.12. United Kingdom Market for Wound Care Growth Factors
4.8.2. Germany
4.8.2.1. Germany Market for Traditional Adhesive Dressings
4.8.2.2. Germany Market for Traditional Gauze Dressings
4.8.2.3. Germany Market for Non-Adherent Dressings
4.8.2.4. Germany Market for Film Dressings
4.8.2.5. Germany Market for Foam Dressings
4.8.2.6. Germany Market for Hydrogel Dressings
4.8.2.7. Germany Market for Hydrocolloid Dressings
4.8.2.8. Germany Market for Alginate Dressings
4.8.2.9. Germany Market for Antimicrobial Dressings
4.8.2.10. Germany Market for Negative Pressure Wound Therapy Devices
4.8.2.11. Germany Market for Bioengineered Skin and Skin Substitutes
4.8.2.12. Germany Market for Wound Care Growth Factors
4.8.3. France
4.8.3.1. France Market for Traditional Adhesive Dressings
4.8.3.2. France Market for Traditional Gauze Dressings
4.8.3.3. France Market for Non-Adherent Dressings
4.8.3.4. France Market for Film Dressings
4.8.3.5. France Market for Foam Dressings
4.8.3.6. France Market for Hydrogel Dressings
4.8.3.7. France Market for Hydrocolloid Dressings
4.8.3.8. France Market for Alginate Dressings
4.8.3.9. France Market for Antimicrobial Dressings
4.8.3.10. France Market for Negative Pressure Wound Therapy Devices
4.8.3.11. France Market for Bioengineered Skin and Skin Substitutes
4.8.3.12. France Market for Wound Care Growth Factors
4.8.4. Italy
4.8.4.1. Italy Market for Traditional Adhesive Dressings
4.8.4.2. Italy Market for Traditional Gauze Dressings
4.8.4.3. Italy Market for Non-Adherent Dressings
4.8.4.4. Italy Market for Film Dressings
4.8.4.5. Italy Market for Foam Dressings
4.8.4.6. Italy Market for Hydrogel Dressings
4.8.4.7. Italy Market for Hydrocolloid Dressings
4.8.4.8. Italy Market for Alginate Dressings
4.8.4.9. Italy Market for Antimicrobial Dressings
4.8.4.10. Italy Market for Negative Pressure Wound Therapy Devices
4.8.4.11. Italy Market for Bioengineered Skin and Skin Substitutes
4.8.4.12. Italy Market for Wound Care Growth Factors
4.8.5. Spain
4.8.5.1. Spain Market for Traditional Adhesive Dressings
4.8.5.2. Spain Market for Traditional Gauze Dressings
4.8.5.3. Spain Market for Non-Adherent Dressings
4.8.5.4. Spain Market for Film Dressings
4.8.5.5. Spain Market for Foam Dressings
4.8.5.6. Spain Market for Hydrogel Dressings
4.8.5.7. Spain Market for Hydrocolloid Dressings
4.8.5.8. Spain Market for Alginate Dressings
4.8.5.9. Spain Market for Antimicrobial Dressings
4.8.5.10. Spain Market for Negative Pressure Wound Therapy Devices
4.8.5.11. Spain Market for Bioengineered Skin and Skin Substitutes
4.8.5.12. Spain Market for Wound Care Growth Factors
4.8.6. Rest of Europe
4.8.6.1. Rest of Europe Market for Traditional Adhesive Dressings
4.8.6.2. Rest of Europe Market for Traditional Gauze Dressings
4.8.6.3. Rest of Europe Market for Non-Adherent Dressings
4.8.6.4. Rest of Europe Market for Film Dressings
4.8.6.5. Rest of Europe Market for Foam Dressings
4.8.6.6. Rest of Europe Market for Hydrogel Dressings
4.8.6.7. Rest of Europe Market for Hydrocolloid Dressings
4.8.6.8. Rest of Europe Market for Alginate Dressings
4.8.6.9. Rest of Europe Market for Antimicrobial Dressings
4.8.6.10. Rest of Europe Market for Negative Pressure Wound Therapy Devices
4.8.6.11. Rest of Europe Market for Bioengineered Skin and Skin Substitutes
4.8.6.12. Rest of Europe Market for Wound Care Growth Factors
4.9. Asia/Pacific
4.9.1. Japan
4.9.1.1. Japan Market for Traditional Adhesive Dressings
4.9.1.2. Japan Market for Traditional Gauze Dressings
4.9.1.3. Japan Market for Non-Adherent Dressings
4.9.1.4. Japan Market for Film Dressings
4.9.1.5. Japan Market for Foam Dressings
4.9.1.6. Japan Market for Hydrogel Dressings
4.9.1.7. Japan Market for Hydrocolloid Dressings
4.9.1.8. Japan Market for Alginate Dressings
4.9.1.9. Japan Market for Antimicrobial Dressings
4.9.1.10. Japan Market for Negative Pressure Wound Therapy Devices
4.9.1.11. Japan Market for Bioengineered Skin and Skin Substitutes
4.9.1.12. Japan Market for Wound Care Growth Factors
4.9.2. Korea
4.9.2.1. Korea Market for Traditional Adhesive Dressings
4.9.2.2. Korea Market for Traditional Gauze Dressings
4.9.2.3. Korea Market for Non-Adherent Dressings
4.9.2.4. Korea Market for Film Dressings
4.9.2.5. Korea Market for Foam Dressings
4.9.2.6. Korea Market for Hydrogel Dressings
4.9.2.7. Korea Market for Hydrocolloid Dressings
4.9.2.8. Korea Market for Alginate Dressings
4.9.2.9. Korea Market for Antimicrobial Dressings
4.9.2.10. Korea Market for Negative Pressure Wound Therapy Devices
4.9.2.11. Korea Market for Bioengineered Skin and Skin Substitutes
4.9.2.12. Korea Market for Wound Care Growth Factors
4.9.3. Rest of Asia/Pacific
4.9.3.1. Rest of Asia/Pacific Market for Traditional Adhesive Dressings
4.9.3.2. Rest of Asia/Pacific Market for Traditional Gauze Dressings
4.9.3.3. Rest of Asia/Pacific Market for Non-Adherent Dressings
4.9.3.4. Rest of Asia/Pacific Market for Film Dressings
4.9.3.5. Rest of Asia/Pacific Market for Foam Dressings
4.9.3.6. Rest of Asia/Pacific Market for Hydrogel Dressings
4.9.3.7. Rest of Asia/Pacific Market for Hydrocolloid Dressings
4.9.3.8. Rest of Asia/Pacific Market for Alginate Dressings
4.9.3.9. Rest of Asia/Pacific Market for Antimicrobial Dressings
4.9.3.10. Rest of Asia/Pacific Market for Negative Pressure Wound Therapy Devices
4.9.3.11. Rest of Asia/Pacific Market for Bioengineered Skin and Skin Substitutes
4.9.3.12. Rest of Asia/Pacific Market for Wound Care Growth Factors
4.9.4. Rest of World
4.9.4.1. Rest of World Market for Traditional Adhesive Dressings
4.9.4.2. Rest of World Market for Traditional Gauze Dressings
4.9.4.3. Rest of World Market for Non-Adherent Dressings
4.9.4.4. Rest of World Market for Film Dressings
4.9.4.5. Rest of World Market for Foam Dressings
4.9.4.6. Rest of World Market for Hydrogel Dressings
4.9.4.7. Rest of World Market for Hydrocolloid Dressings
4.9.4.8. Rest of World Market for Alginate Dressings
4.9.4.9. Rest of World Market for Antimicrobial Dressings
4.9.4.10. Rest of World Market for Negative Pressure Wound Therapy Devices
4.9.4.11. Rest of World Market for Bioengineered Skin and Skin Substitutes
4.9.4.12. Rest of World Market for Wound Care Growth Factors
SECTION 5: COMPANY PROFILES (preliminary, subject to change)
5.1. 3M Health Care
5.2. ACell
5.3. AcryMed Inc.
5.4. Agennix Incorporated
5.5. AGT Sciences Ltd
5.6. Altrika Ltd
5.7. Anika Therapeutics
5.8. Argentum Medical
5.9. Avita Medical
5.10. B. Braun Melsungen AG
5.11. Biopharm GmbH
5.12. Biotime, Inc.
5.13. BSN Medical GmbH
5.14. Cardium Therapeutics
5.15. CliniMed Limited
5.16. Coloplast Group
5.17. Covalon Technologies, Ltd.
5.18. ConvaTec Inc.
5.19. Cook Biotech, Inc.
5.20. Covidien
5.21. Cytogenix
5.22. Cytomedix
5.23. Derma Sciences, Inc.
5.24. DeRoyal Industries Inc.
5.25. Diapulse Corporation of America
5.26. Eqalix, Inc.
5.27. Euroderm AG
5.28. Gentell Inc
5.29. Geritrex Corp.
5.30. Hartmann Group
5.31. Hollister Incorporated
5.32. Imbed Biosciences, Inc.
5.33. Integra LifeSciences, Inc.
5.34. Kendall (Covidien)
5.35. Kinetic Concepts, Inc. (Acelity)
5.36. Kuros Biosurgery AG
5.37. Laboratoires Urgo
5.38. LifeCell Corporation (Acelity)
5.39. Lohmann & Rauscher International GmbH and Co. KG
5.40. Macrocure
5.41. Medline Industries
5.42. Microban International Ltd.
5.43. MicroVas Technologies, Inc
5.44. Mölnlycke Health Care AB
5.45. NovaBay Pharmaceuticals
5.46. Oculus Innovative Sciences
5.47. Organogenesis Inc
5.48. Osiris Therapeutics
5.49. Perry Baromedical
5.50. RXi Pharmaceuticals
5.51. SafeBlood Technologies
5.52. Sanofi Biosurgery (formerly Genzyme Biosurgery)
5.53. SANUWAVE Health, Inc.
5.54. Shire Regenerative Medicine
5.55. Smith & Nephew plc
5.56. Soluble Solutions, LLC
5.57. Spiracur, Inc.
5.58. Systagenix, Inc. (Acelity)
5.59. TEI Biosciences
5.60. Tissue Regeneration Technologies, LLC
5.61. UDL Laboratories
5.62. Uluru, Inc.
5.63. Vomaris Innovations, Inc.

APPENDIX: COMPANY DIRECTORY


Worldwide Wound Management, Forecast to 2024:
Established and Emerging Products, Technologies and Markets
in the Americas, Europe, Asia/Pacific and Rest of World
· 350 pages · 200 Exhibits · 75 Company Profiles · Report #S251 · October 2015
(Click for full report description)

Price: $4,250 (print or PDF; add $200 for both).
Pre-publication $1,000 discount.
Site/Global License also available.

Order online or send us your order form.

 

Coverage in 2015 global spine surgery technology report

The MedMarket Diligence report, “Global Market For Medical Device Technologies in Spine Surgery, 2014-2021” (link), is a detailed market and technology assessment and forecast of the products and technologies in the management of diseases and disorders of the spine. The report describes the diseases and disorders of the spine, characterizing the patient populations, their current clinical management, and trends in clinical management as new techniques and technologies are expected to be developed and emerge. The report details the currently available products and technologies, and the manufacturers offering them. The report details the products and technologies under development and markets for each in spine surgery. The report provides the current and forecast market to 2021, by region/country, of procedures and manufacturer revenues.

Technologies covered:

  • Cervical implants
  • Thoracolumbar implants
  • Minimally invasive implants
  • Non-fusion implants
  • Orthobiologics

Geographic market detail:

  • North America — United States, Canada
  • Europe — Germany, France, Spain, Italy, United Kingdom
  • Asia/Pacific — Japan, India, China
  • Central and Latin America
  • Rest of World

Selected (published report includes over 100 companies) list of companies included in the report:

  • Accel Spine
  • Advanced Spine Fixation Systems Inc
  • Aesculap
  • Alphatec Spine (Scient’x Groupe S.A.)
  • Apollo
  • Argomedical AG
  • Baumer S.A.
  • Beijing Montagne Medical Device Co.
  • Biedermann Motech GmbH & Co. KG
  • Biomatlante
  • Biotech GmbH
  • Biotechni
  • BIOTEK – Chetan Meditech Pvt. Ltd
  • Bonovo Orthopedics Inc
  • coLigne AG
  • DePuy Synthes
  • Dieter Marquardt Medizintechnik GmbH
  • ESKA Implants AG
  • Exactech Spine
  • Gerraspine AG
  • Globus Medical
  • Graftys
  • Integra LifeSciences
  • Japan Medical Dynamic Marketing (MDM) INC
  • K2M
  • Kyocera Medical Corporation
  • LDR Medical
  • Medicrea
  • Medtronic Spinal and Biologics
  • Medyssey Spine Ltd (Zimmer)
  • Nakashima Medical Co. Ltd
  • Norer Medical Group (Xinrong Best Medical Instrument Co. Limited)
  • NuVasive
  • Onur MEDiKAL San. Ve Tic Ltd. Sti.
  • Orthopaedic & Spine Development
  • Osteotech
  • Seohancare co. ltd
  • Solco Biomedical
  • Sozhou Kangli
  • Spineart
  • Spinelab Ltd.
  • Stryker Spine
  • Surgival-Grupo Cosias
  • Ulrich GmbH & Co.KG
  • Wright Medical Technology
  • Zimmer Biomet

For complete details on this report, including ordering online, see link.

Technology advances in spine surgery

Manufacturers, clinicians and others focusing on technology advancement in spine surgery are not developing radical innovations, but are making enough incremental improvements in a number of ways that result in growth in the industry.  Most improvements fall into a number of categories:

Screen Shot 2015-09-14 at 7.29.36 AMNew materials technologies: Historically, spinal fusion instrumentation was fabricated from metallic biomaterials, including stainless steel and titanium alloy, because of their strength and fatigue resistance. However, one key drawback of these metallic implants is incompatibility with diagnostic imaging, including MRI and CT scans, which are crucial for visualizing changes to the spinal cord and vital soft tissue structures of the spine. To overcome these issues a variety of new materials such as biocompatible carbon fiber-reinforced (CFR) thermoplastic materials and implantable polyetheretherketone (PEEK) polymers were examined as an alternative to the traditional materials. In addition to biocompatibility, biostability and compatibility with diagnostic imaging, these advanced thermoplastic polymers provide a range of mechanical properties that are well suited to the demanding environment of spinal implants.

Implantable PEEK polymers are available today in an array of formulations, ranging from unfilled grades with varying molecular weight, to image-contrast and carbon fiber-reinforced grades. The first implantable unfilled PEEK polymer–PEEK-OPTIMA was pioneered in 1999 by United Kingdom-based Invibio Biomaterial Solutions. Introduced by Invibio in 2007 to provide controlled visibility through X-ray, CT and MRI technologies, image-contrast grades offer tailored opacity that allows for easier post-operative device placement verification by surgeons and clear assessment of the healing site. Also launched by Invibio in 2007, carbon fiber-reinforced (CFR) grades provide significantly increased strength and stiffness as well as a modulus similar to that of cortical bone.

The CD HORIZON LEGACY PEEK Rod from Medtronic Sofamor Danek and the EXPEDIUM™ PEEK Rod System from DePuy Spine, Inc., are examples, in which these polyetheretherketone (PEEK) polymers are radiolucent and have the ability to reduce scatter and artifact from CT and MRI images. [Picture source: MRI scan via Shutterstock]

Screen Shot 2015-09-14 at 7.24.36 AMComputer aided fixation of spinal implants: A number of proprietary techniques are being developed that provide computer or robotic alignment for the placement of spinal implants. Current research ensures that further developments will occur resulting in more extensive use of computer aided fixation. [Picture source: NIH]

 

percutaneous spineMinimally invasive spine surgery: Manufacturers have development technologies in percutaneous and endoscopic approaches to spine surgery that are having (and will continue to have) a significant impact on patients, clinical practice and the market for spine products.  It is producing all the expected benefits of less invasiveness — less traumatic surgery results in shorter recovery times and better outcomes and opens up spine surgery to more elderly, infirm and other patients for whom traditional spine surgery would be contraindicated. [Image: Handbook of Minimally Invasive and Percutaneous Spine Surgery; allamericanspeakers.com]

 

Screen Shot 2015-09-14 at 7.19.47 AMVariable axis screw systems: A variable axis screw system is a pedicular screw system that features a variable-axis head, which offers a ±25 degrees of angulation. The system also offers a pre-contoured rod. The contoured rod, along with the angulation available in the screw head, alleviates the need for rod contouring. The screw also features a pre-assembled head and double lead thread. The pre-assembled head reduces the steps required for construct assembly and the double lead thread increase the speed of screw insertion and construct assembly so that the overall operative time can be shortened. [Picture source: DePuy Synthes]

Products, technologies, markets, companies and opportunities in the spine surgery industry are the focus of the MedMarket Diligence Report #M540, “Global Market for Medical Device Technologies in Spine Surgery, 2014-2021: Established and Emerging Products, Technologies and Markets in the Americas, Europe, Asia/Pacific and Rest of World.” The next five purchasers of this report (any option) will receive a 25% discount off the published price online by entering the coupon code “spinepricectomy”.

 

Global Markets for Medical Devices in Spine Surgery, Forecast to 2021

The market for spinal implants and associated spinal fusion products has evolved dramatically over the last several decades as a result of significant advances in the understanding of spinal biomechanics, the proliferation of sophisticated spinal instrumentation devices, surgical advances in bone fusion techniques, refinement of anterior approaches to the spine and the emergence and development of microsurgical, minimally invasive methods and robotics. As a result of these advances it is now possible to stabilize every segment of the spine successfully, regardless of the offending pathology.

Prior to these developments, the orthopedic industry had traditionally regarded spinal surgery as a “Cinderella” segment that — far from being a major market segment — was almost regarded as a service area supporting a relatively small number of highly specialized surgeons focusing on the clinical issues associated with the vertebral column. In contrast, by the beginning of the new millennia it became clear that an orthopaedic industry seeking to provide optimized earnings and value to share holders had identified this area as a major unmet need in which the demand to resolve an increasingly wide range of spinal conditions was growing exponentially.

In response to these developments, and in recognition that the market for spinal implants and associated spinal fusion products was and is growing, orthopedic companies have realigned their strategic approach by:

  • Providing greater resources to further product development.
  • Expanding of sales and marketing resources
  • Growing new and emerging geographic regions

It is anticipated that, collectively, these elements will further open the door to the development of implantable devices that can identically reproduce the elements of the spine that need to be reinforced or replaced by artificial. Accordingly, use of spinal fusion and instrumentation is anticipated to increase in the foreseeable future and continue to represent a better than average growth area in medtech.

 

 

Screen Shot 2015-08-18 at 8.20.21 AM

Source: MedMarket Diligence, LLC; Report #M540


MedMarket Diligence, LLC, has completed an analysis entitled, “Global Market For Medical Device Technologies in Spine Surgery, 2014-2020”. The report (#M540) will be published August 21, 2015, and will be downloadable in PDF and available in print for single, site, and global licenses. The report is described in detail, with a complete table of contents and list of exhibits, at link.

Absolute and Relative Growth in Wound Closure Product Sales Worldwide

(See the 2016 published report #S290, “Sealants, Glues, Hemostats, 2016-2022”.)

Medtech manufacturers interested in “growth” markets need to consider the relative versus absolute. Nascent markets can growth from $1 million sales in year 1 to $2 million in year 2, obviously a 100% increase. But in multi-billion markets, a $1 million increase will elicit a yawn from all but the smallest manufacturers.

Just as an exercise, I ranked the growth rates for sales of wound closure products detailed in our Report #S192 by both the absolute sales growth from 2014 to 2018 and the compound annual growth rate over this period. To reveal the differences even further, I ranked all combinations of geographic area and wound closure product type. Partial results — just the top growth rankings, since the list is too long to show all — are shown side by side below (click on the chart to see a more legible version).

Wound Closure Sales Growth, Absolute and Relative, 2014-2018

Screen Shot 2015-05-25 at 9.40.11 AM

Source: “Worldwide Surgical Sealants, Glues, and Wound Closure Markets, 2013-2018”, Report #S192.

Even though tapes, sutures and staples have very modest growth rates in many geographic markets, their current dollar volume sales make such growth much more significant in absolute terms.

 

(See the 2016 published report #S290, “Sealants, Glues, Hemostats, 2016-2022”.)

Surgical Sealants: Advanced Technologies in Well Developed Markets

Advanced technologies are frequently developed in well developed economies, then migrate to other economies over time. Consequently, relatively new technologies tend to be more dominant in the well developed economies while relatively old technologies tend to be more dominant in the developing economies.

Case in point, surgical sealants for wound management versus surgical tapes, the former relatively new (and advanced) and the latter relatively old.

Screen Shot 2015-03-21 at 12.45.52 PM

Source: MedMarket Diligence, LLC; Report #S192

Surgical Sealants and Glues Sales Growth

Aside from demonstrating clinical utility in wound sealing and closure on their own, sealants and glues are emerging as important adjunctive tools for sealing staple and suture lines, and some of these products also are being employed as general hemostatic agents to control bleeding in the surgical field. Manufacturers have also developed surgical sealants and glues that are designed for specific procedures – particularly those in which staples and sutures are difficult to employ or where additional reinforcement of the internal suture/staple line provides an important safety advantage.

Sales of surgical sealants and glues have become as common in some surgical procedures as sutures and staples in well developed markets (U.S., Europe and Japan), but their use continues to expand in both stand alone and adjunctive use with other wound closure. Emerging markets, especially in Asia will drive nearly double these growth rates. All told, the global surgical sealants and glues market will eclipse $2 billion by 2018 on compound annual growth of 9.4%.

Screen Shot 2015-01-27 at 2.45.11 PMSource: MedMarket Diligence, LLC; Report #S192.

 

Technology Migration in Global Wound Closure Markets

Drawn from our recent report on the global market for wound closure products, Report #S192, the distribution of the technologies on the market now, and in the future, for wound closure encompassing sutures & staples, tapes, hemostats, sealants & glues and vascular closure devices reveals the continued migration of advanced technologies (vascular closure, hemostats, glues & sealants) from western economies to the developing markets. Simultaneously, the more well established technologies (tapes, sutures & staples) are showing modest growth in western economies and robust growth in developing economies.

Below are illustrated the percentage of total worldwide market for each wound closure technology type by country/region.

Screen Shot 2014-11-10 at 10.29.31 AM

Source: MedMarket Diligence, LLC; Report #S192

Screen Shot 2014-11-10 at 10.29.41 AM

Source: MedMarket Diligence, LLC; Report #S192

Screen Shot 2014-11-10 at 10.30.22 AM

Source: MedMarket Diligence, LLC; Report #S192

Screen Shot 2014-11-10 at 10.30.58 AM

Source: MedMarket Diligence, LLC; Report #S192

Screen Shot 2014-11-10 at 10.31.08 AM

Source: MedMarket Diligence, LLC; Report #S192